Showing results (21-30 of 224) with videos related to

Sort By:
Pageof 23
Current Hypertension Reports|May 31, 2024
Hypertension and Cardiovascular Outcomes in Inflammatory and Autoimmune Diseases: A Systematic Review and Meta-analysisMarie Barozet, Olivier Le Tilly, Theodora Bejan-Angoulvant, et al.
Cardiology|August 9, 2011
Accelerated coronary atherosclerosis revealed by arrhythmogenic coronary spasmFranck Sibellas, Nicolas Girerd, Theodora Bejan-Angoulvant, et al.
Therapeutic Drug Monitoring|July 14, 2017
Therapeutic Drug Monitoring of Biopharmaceuticals May Benefit From Pharmacokinetic and Pharmacokinetic-Pharmacodynamic ModelingChristophe Passot, Mieke F Pouw, Denis Mulleman, et al.
European Journal of Epidemiology|February 12, 2008
Hazard regression model and cure rate model in colon cancer relative survival trends: are they telling the same story?Theodora Bejan-Angoulvant, Anne-Marie Bouvier, Nadine Bossard, et al.
Therapeutic Drug Monitoring|May 10, 2017
Rationale for Therapeutic Drug Monitoring of Biopharmaceuticals in Inflammatory DiseasesGilles Paintaud, Christophe Passot, David Ternant, et al.
British Journal of Clinical Pharmacology|January 19, 2022
Is CD25 blockade optimal in kidney transplant patients treated with basiliximab? A target-mediated drug disposition modelOlivier Le Tilly, Philippe Gatault, Christophe Baron, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 10, 2019
Plasma creatinine and amyotrophic lateral sclerosis prognosis: a systematic review and meta-analysisDébora Lanznaster, Theodora Bejan-Angoulvant, Franck Patin, et al.
Bioanalysis|August 3, 2017
Development and validation of an enzyme-linked immunosorbent assay to measure free eculizumab concentration in serumChristophe Passot, Céline Desvignes, David Ternant, et al.
Cancer Chemotherapy and Pharmacology|March 3, 2018
A novel way to manage trastuzumab cardiotoxicityDiaddin Hamdan, François Darrouzain, Theodora Bejan-Angoulvant, et al.
Pageof 23